JP2017527304A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527304A5
JP2017527304A5 JP2017523184A JP2017523184A JP2017527304A5 JP 2017527304 A5 JP2017527304 A5 JP 2017527304A5 JP 2017523184 A JP2017523184 A JP 2017523184A JP 2017523184 A JP2017523184 A JP 2017523184A JP 2017527304 A5 JP2017527304 A5 JP 2017527304A5
Authority
JP
Japan
Prior art keywords
genes
subject
lung cancer
identified
clusters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523184A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017527304A (ja
JP6775499B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/040437 external-priority patent/WO2016011068A1/en
Publication of JP2017527304A publication Critical patent/JP2017527304A/ja
Publication of JP2017527304A5 publication Critical patent/JP2017527304A5/ja
Application granted granted Critical
Publication of JP6775499B2 publication Critical patent/JP6775499B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523184A 2014-07-14 2015-07-14 肺がん状態の評価方法 Active JP6775499B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462024456P 2014-07-14 2014-07-14
US62/024,456 2014-07-14
US201562160403P 2015-05-12 2015-05-12
US62/160,403 2015-05-12
PCT/US2015/040437 WO2016011068A1 (en) 2014-07-14 2015-07-14 Methods for evaluating lung cancer status

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020126239A Division JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Publications (3)

Publication Number Publication Date
JP2017527304A JP2017527304A (ja) 2017-09-21
JP2017527304A5 true JP2017527304A5 (https=) 2018-08-30
JP6775499B2 JP6775499B2 (ja) 2020-10-28

Family

ID=55078998

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017523184A Active JP6775499B2 (ja) 2014-07-14 2015-07-14 肺がん状態の評価方法
JP2020126239A Pending JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020126239A Pending JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Country Status (8)

Country Link
US (2) US20160130656A1 (https=)
EP (2) EP3169814B1 (https=)
JP (2) JP6775499B2 (https=)
KR (1) KR102461014B1 (https=)
CN (2) CN106795565B (https=)
AU (2) AU2015289758B2 (https=)
CA (1) CA2954169A1 (https=)
WO (1) WO2016011068A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
EP3626308A1 (en) 2013-03-14 2020-03-25 Veracyte, Inc. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3215170A4 (en) 2014-11-05 2018-04-25 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP4180531A3 (en) 2016-05-12 2023-08-23 Trustees of Boston University Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
AU2017281099A1 (en) 2016-06-21 2019-01-03 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
EP3513344A1 (en) * 2016-09-14 2019-07-24 Philip Morris Products S.a.s. Systems, methods, and gene signatures for predicting a biological status of an individual
US11244764B2 (en) * 2016-12-21 2022-02-08 Cerner Innovation, Inc. Monitoring predictive models
CN110662844A (zh) * 2017-05-22 2020-01-07 内盖夫生物技术国家研究所有限公司 用于肺癌的诊断的生物标志物
JP2020522690A (ja) * 2017-06-02 2020-07-30 ベラサイト インコーポレイテッド 肺疾病の特定又はモニタリング方法及びシステム
US12227808B2 (en) 2017-12-19 2025-02-18 The Wistar Institute Of Anatomy And Biology Compostions and methods for diagnosing lung cancers using gene expression profiles
US12023149B2 (en) 2018-07-02 2024-07-02 3M Innovative Properties Company Sensing system and method for monitoring time-dependent processes
KR102274564B1 (ko) * 2018-07-03 2021-07-07 (주) 프로큐라티오 빅데이터분석기반 암진단장치
CN108998531B (zh) * 2018-08-31 2021-10-01 昆明医科大学第一附属医院 肺癌下调长链非编码rna标志物及其应用
CN109615075B (zh) * 2018-12-14 2022-08-19 大连海事大学 一种基于多层聚类模型的居民日常行为识别方法
US20210287795A1 (en) * 2020-03-12 2021-09-16 Optellum Limited Cad device and method for assisting an estimation of lung disease from medical images
CN111455057B (zh) * 2020-03-30 2021-10-26 中国医学科学院肿瘤医院 用于肺癌诊断的试剂盒、装置及方法
CN114317746B (zh) * 2020-03-30 2022-09-23 中国医学科学院肿瘤医院 外泌体arpc5、ypel2等在肺癌诊断中的应用
CN111863130A (zh) * 2020-04-07 2020-10-30 至本医疗科技(上海)有限公司 肿瘤免疫治疗预后标志物的筛选方法及应用
CN112034185A (zh) * 2020-09-11 2020-12-04 上海市胸科医院 Gpr110、vegfr、cd34在鉴别肺腺癌亚型中的用途
EP4314323A4 (en) * 2021-03-29 2025-06-04 Veracyte, Inc. METHODS AND SYSTEMS FOR IDENTIFYING A LUNG DISORDER
US12094107B2 (en) * 2021-04-07 2024-09-17 Optellum Limited CAD device and method for analyzing medical images
CN113444796B (zh) * 2021-06-29 2023-02-07 浙江医院 与肺癌相关的生物标志物及其在诊断癌症中的应用
KR102417602B1 (ko) * 2021-11-30 2022-07-07 (주)플라스바이오 인공 지능 모델 기반 종양 관리 장치 및 방법
CN114854755B (zh) * 2022-05-30 2023-05-23 陕西师范大学 一种抑制vstm2l表达的慢病毒载体及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003234623A1 (en) * 2002-05-16 2003-12-02 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening
EP3305919A1 (en) * 2003-06-10 2018-04-11 The Trustees of Boston University Detection methods for disorders of the lung
CA2552686A1 (en) 2003-11-12 2005-05-26 Trustees Of Boston University Isolation of nucleic acid from mouth epithelial cells
US20100035244A1 (en) * 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2007142936A2 (en) * 2006-05-30 2007-12-13 Duke University Prediction of lung cancer tumor recurrence
KR101443214B1 (ko) * 2007-01-09 2014-09-24 삼성전자주식회사 폐암 환자 또는 폐암 치료를 받은 폐암 환자의 폐암 재발 위험을 진단하기 위한 조성물, 키트 및 마이크로어레이
AU2008251877A1 (en) 2007-05-08 2008-11-20 Picobella Llc Methods for diagnosing and treating prostate and lung cancer
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
US20100055689A1 (en) 2008-03-28 2010-03-04 Avrum Spira Multifactorial methods for detecting lung disorders
GB0811413D0 (en) * 2008-06-20 2008-07-30 Kanton Basel Stadt Gene expression signatures for lung cancers
WO2012006632A2 (en) * 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
KR20130017525A (ko) * 2011-08-11 2013-02-20 주식회사 젠닥스 대장암, 유방암, 신장암 또는 갑상선암의 조기 진단을 위한 바이오 마커 및 이의 용도
EP2751290A4 (en) * 2011-08-29 2015-07-15 Cardiodx Inc METHOD AND COMPOSITIONS FOR DETERMINING A SMOKE STATUS
CA2799163C (en) * 2011-12-18 2025-01-07 20/20 Genesystems, Inc. Methods and algorithms for aiding in the detection of cancer
WO2013163568A2 (en) * 2012-04-26 2013-10-31 Allegro Diagnostics Corp. Methods for evaluating lung cancer status
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers

Similar Documents

Publication Publication Date Title
JP2017527304A5 (https=)
US20250297325A1 (en) Source of origin deconvolution based on methylation fragments in cell-free dna samples
US12462896B2 (en) Method and system for predicting response to immune anticancer drugs
WO2019153595A1 (zh) 慢阻肺发病风险预测方法、服务器及计算机可读存储介质
WO2016094330A3 (en) Methods and machine learning systems for predicting the liklihood or risk of having cancer
US20200239964A1 (en) Anomalous fragment detection and classification
CN110392740A (zh) 确定人群样本生物指标集、预测生物学年龄的方法及其应用
JP2014516413A5 (https=)
JP2009516501A5 (https=)
JP2013520960A5 (https=)
CN106295241A (zh) 基于brca1和brca2突变的乳腺癌患病风险评估算法
EP4105943A1 (en) Method and system for predicting reaction to immuno-oncology agent
EA201400131A1 (ru) Новый классификатор для молекулярной классификации миеломной болезни
CN106951682B8 (zh) 一种基于不确定性的山丘区水文模型与数据精度匹配方法
CN105095595A (zh) 基于种群聚集程度的粒子群算法
JP2016515390A5 (https=)
Udagawa et al. Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease
CN105654174B (zh) 用于预测的系统和方法
CN107851136B (zh) 用于对未知重要性的变体划分优先级顺序的系统和方法
CN102419791A (zh) 人类常见病遗传风险评估方法
CN104462215B (zh) 一种基于时间序列的科技文献被引用数目预测方法
JP2019532410A5 (https=)
CN116959719A (zh) 一种数据处理方法及非小细胞肺癌脑转移风险预测系统
Singer et al. Comment on Adamzik et al.: An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality
Wirtz et al. Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF